Heim J, Vasquez JG, Schenkel B, Bhatia N. Patients’ quality of life in a Phase 4 real-world study of tildrakizumab in moderate-to-severe plaque psoriasis. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s135. Available from: https://jofskin.org/33014/index.php/skin/article/view/2006